RBL LLC Welcomes Chris Duke as New Operating Partner to Boost Biotech Ventures RBL LLC has appointed Chris Duke as operating partner, bringing rich experience in biopharmaceuticals to enhance biotech venture creation, focusing on breakthrough medical technologies.

RBL LLC Welcomes Chris Duke as New Operating Partner to Boost Biotech Ventures #United_States #biopharmaceuticals #Houston #RBL_LLC #Chris_Duke

RBL LLC Launches SteerBio, Pioneering Therapy for Lymphedema with $18.2 Million Federal Funding RBL LLC's new spin-off, SteerBio, has launched with $18.2 million in federal funding for a novel therapy targeting lymphedema, aiming to change patient lives.

RBL LLC Launches SteerBio, Pioneering Therapy for Lymphedema with $18.2 Million Federal Funding #USA #Houston #Lymphedema #RBL_LLC #SteerBio

RBL LLC and Carnrite Ventures: Revolutionizing Biotech with Strategic Investment RBL LLC announces a strategic investment from Carnrite Ventures, aimed at accelerating biotech innovations and developing groundbreaking medical technologies.

RBL LLC and Carnrite Ventures: Revolutionizing Biotech with Strategic Investment #United_States #Houston #Biotech_Innovation #RBL_LLC #Carnrite_Ventures

RBL LLC Gains Investment from Modi Ventures to Boost Biotech Startups RBL LLC has received strategic investment from Modi Ventures, set to accelerate the growth of biotech startups and enhance the development of medical technologies.

RBL LLC Gains Investment from Modi Ventures to Boost Biotech Startups #biotech #RBL_LLC #Modi_Ventures

Mark Hensley Appointed Senior Adviser at RBL LLC to Enhance Biotech Ventures Mark Hensley has joined RBL LLC as a senior adviser, aiming to accelerate the development of groundbreaking life sciences technologies.

Mark Hensley Appointed Senior Adviser at RBL LLC to Enhance Biotech Ventures #United_States #biotech #Houston #RBL_LLC #Mark_Hensley

RBL LLC Strengthens Leadership Team with James Watson's Appointment RBL LLC has appointed James Watson to its board of directors, enhancing its leadership and commitment to advancing biotech innovations and therapies.

RBL LLC Strengthens Leadership Team with James Watson's Appointment #United_States #Houston #Rice_University #RBL_LLC #James_Watson

RBL LLC Unveils Sentinel BioTherapeutics for Cancer Treatment at ASCO 2025 RBL LLC has launched Sentinel BioTherapeutics, a clinical-stage company, at the ASCO 2025 meeting, showcasing its innovative cancer therapies.

RBL LLC Unveils Sentinel BioTherapeutics for Cancer Treatment at ASCO 2025 #USA #Houston #RBL_LLC #Sentinel_BioTherapeutics #IL-2_therapy

RBL LLC Appoints Devyn Smith to Board of Directors, Boosting Biotech Innovation in Houston RBL LLC has welcomed Devyn Smith to its board, a move set to enhance biotech ventures from Rice University by accelerating groundbreaking therapies.

RBL LLC Appoints Devyn Smith to Board of Directors, Boosting Biotech Innovation in Houston #United_States #Houston #Biotech_Innovation #RBL_LLC #Devyn_Smith

Innovative Cancer-Fighting Implant Shows Hope in Treating Multiple Tumor Types Researchers at Rice University have developed an ingenious implant that can effectively target and treat challenging cancers like melanoma and more.

Innovative Cancer-Fighting Implant Shows Hope in Treating Multiple Tumor Types #United_States #Houston #Cancer_Treatment #Rice_University #RBL_LLC

Celebrating Innovation: Rice Biotech Launch Pad Hosts RBL LLC's Grand Opening Event Join us on May 5 for the grand opening of RBL LLC at the Rice Biotech Launch Pad. Hear from industry leaders Robert Langer and Robert Ruffolo.

Celebrating Innovation: Rice Biotech Launch Pad Hosts RBL LLC's Grand Opening Event #United_States #Houston #Robert_Langer #Rice_Biotech #RBL_LLC